Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs

Update your browser to view ScienceDirect.

Request details:

Request ID: 8c9686a078fccf29-LAX
IP: 47.97.18.252
UTC time: 2024-09-26T22:00:16+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4